Analysts Downgrade Applied Materials and Outlook Therapeutics
Morgan Stanley and BTIG analysts lowered ratings on Applied Materials and Outlook Therapeutics. The changes were among several analyst adjustments reported for the trading week.
247wallst.comMorgan Stanley analyst Shane Brett downgraded Applied Materials Inc from Overweight to Equal-Weight and set a $502 price target. 62 on Friday. BTIG analyst Julian Harrison downgraded Outlook Therapeutics Inc from Buy to Neutral.
23 on Friday. The downgrades were among analyst rating changes issued for the trading week. Additional details on upgrades, downgrades, and initiations are available on Benzinga’s analyst ratings page.
Transparency
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Story details
Related Stories
jns.orgIran Suspends Indirect Talks With U.S. Amid Escalating Israel-Hezbollah Conflict in Lebanon
Iran has stopped all message exchange with the United States, including ongoing talks, in response to Israel's expanded offensive in Lebanon. The suspension was reported by Tasnim News Agency, which is affiliated with the Islamic Revolutionary Guard Corps according to the Jerusal…
Los Angeles TimesPowell Defends Fed Independence in JFK Profile in Courage Award Speech
Former Federal Reserve Chair Jerome Powell received the John F. Kennedy Profile in Courage Award on Sunday at the Kennedy Presidential Library in Boston. He used the occasion to defend the independence of the central bank and other institutions.
france24.comIranian Official: Tehran Manages Strait of Hormuz and Will Not Allow Maritime Blockade
Mohsen Rezaei stated that Iran controls the Strait of Hormuz and will not allow a maritime blockade to continue. Oil prices rose 8 percent on the day of the statements.